Neoadjuvant BKM120 in High-risk Prostate Cancer

NCT01695473 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Lack of Accrual

Conditions

High Risk Prostate Cancer

Interventions

DRUG: BKM120

Sponsor

Won Kim

Collaborators

[object Object]